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Abstract
Background: Adolescence is a critical developmental period regarding exposure to substances. Therefore, it is
important to be able to identify those adolescents who are most vulnerable to substance abuse in the (near) future.
The JOiN study was specifically designed to examine two endophenotypes of adolescent substance use in a normal
risk (NR) and high risk (HR) sample of adolescents: (1) behavioural disinhibition, and (2) individual differences in
stress sensitivity.
Methods: The NR adolescents were part of a longitudinal general population study at the Erasmus Medical Center
in Rotterdam, the Netherlands of children and adolescents initially aged 6 to 18 years old. Three assessment waves
have been nearly completed, and data are available of N = 711 participants for stress sensitivity measures, and of a
subsample of N = 110 for electroencephalography (EEG) measures. Added to this study, HR adolescents who had at
least one parent with a substance use disorder and who were treated by an outpatient clinic of a primary addiction
care provider were approached via their parent(s). In total, N = 83 adolescents formed this HR sample. NR and HR
adolescents participated in standardized stress procedure and EEG procedures in our laboratory. Questionnaires
were filled out on background variables, behavioural and emotional problems, and substance use, and a diagnostic
interview was conducted with adolescents and parents to assess psychopathology symptoms. DNA was collected
through saliva or blood samples.
Discussion: The design of the JOiN study is optimal for examining the predictive role of endophenotypes of
adolescent substance use. The combination of different methods, i.e. stress physiology, electrophysiology, genetics,
and questionnaire data from several informants on a range of behaviours and environmental factors enables the
investigation of the multifactorial nature of adolescent substance use.
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Background
Since 1983, the Department of Child and Adolescent
Psychiatry in Rotterdam, the Netherlands, has conducted
surveys every decade to assess the level of psychiatric
problems in children and youth, to test for time-trends
in the occurrence of these problems, and to (re)validate
the well-known and often used ASEBA instruments in
the Netherlands (South Holland study). Numerous pub-
lications can be found that describe the findings of these
surveys (e.g. [1-5]). As part of that ongoing study, the
Youth in the Netherlands (Jongeren Onderzoek in Neder-
land in Dutch, abbreviated as JOiN) study was initiated.
This study selected adolescents from the survey, aged
12 to 20 years, and enriched this sample with high risk
(HR) youth, of whom at least one parent was in clin-
ical treatment for a substance use disorder (alcohol or
illicit drugs).
Scope of research
Adolescence is a critical developmental period regarding
exposure to substances. Therefore, it is important to
be able to identify those adolescents who are most vul-
nerable to substance abuse in the (near) future. Genetic
susceptibility is one important factor that underlies indi-
vidual vulnerability. For complex multifactorial disorders
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such as substance abuse, the identification of susceptibil-
ity genes may be substantially aided by using quantitative
intermediate phenotypes, or endophenotypes, instead of
dichotomized clinical variables [6]. These endophenotypes
reflect neurobiological pathways to substance abuse. The
JOiN study was specifically designed to examine several
endophenotypes of adolescent substance use. These endo-
phenotypes represent two neurobiological pathways to
substance misuse or abuse: (1) behavioural disinhibition,
as a possible result of altered cognitive functions of the
prefrontal cortex and (2) individual differences in stress
sensitivity. Behavioural disinhibition includes two mea-
sures: (a) the P300 component of the Event-Related
Potential (ERP), which is associated with attentional allo-
cation and context updating processes of working mem-
ory and involves the activation of inhibitory processes
[7], and (b) risky decision making, or reward-associated
decision-making skills, which have been associated with
substance abuse in adults. Likewise, individual differences
in stress physiological responses are represented by two
endophenotypes: measures of stress reactivity of (c) the
hypothalamic-pituitary-adrenal (HPA) axis and (d) the auto-
nomic nervous system (ANS). More details on the mea-
sures of the endophenotypes and the outcomes are
presented in Tables 1 and 2, respectively.
The general aims of the JOiN study are:
(1)to examine the role of endophenotypes, representing
two potentially important underlying pathways
towards substance abuse, that explain individual
resilience and vulnerability to early onset of
substance use and the transition to regular use;
(2)to identify, based on the endophenotypes, the most
vulnerable group of adolescents with regard to
substance misuse and abuse;
(3)to examine the relationship between endophenotypic
characteristics and common and specific DNA
polymorphisms that have been associated with
increased risk for substance abuse in adult
populations.
Methods/design
The JOiN study sample consists of a normal risk (NR)
sample and a high risk (HR) sample. The NR sample is
part of a larger sample that participated in a longitudinal
general population study at the Erasmus MC in Rotter-
dam, the Netherlands of children and adolescents ini-
tially aged 6 to 18 years old [21]. For this larger study,
2567 children and adolescents were randomly drawn
from municipal registers of 35 representative municipal-
ities in the Dutch province of South Holland including
urban and rural areas. Of these 2567 children and ado-
lescents, 2286 were eligible for participation (191 had
parents that did not speak Dutch, 31 had a physical or
mental disability, 31 were unable to be reached (had
missing or faulty contact details), 22 departed the study
area, 6 for whom no person could complete question-
naires). Of the 2286 eligible participants, 1710 (74.8%)
agreed to participate at the baseline assessment wave
(T0), which took place in 2003–2004. Participants did
not differ from non-participants at this baseline assess-
ment in terms of gender (p> .05). The next assessment
wave (T1) of this sample ran from September 2005 until
March 2009. A second follow-up (T2) started in 2009
and is currently nearly completed.
The JOiN study includes a subgroup of participants of
this larger study that took part in a stress and electroen-
cephalography (EEG) procedure at T1 (see Figure 1),
which we refer to as the normal risk (NR) sample. Of
the 1710 participants at T0, n = 1161(67.9%) participants
Table 1 Endophenotypes under study
Behavioural disinhibition
Endophenotype Abbreviation(s) Assessment
(In)efficient allocation of attentional resources in
processing task-relevant cognitive information,
indexed by the P300 amplitude of the Event-Related
brain Potential of an Electroencephalography
P300, ERP, EEG Visual novelty oddball paradigm to elicit P300 ERP
response [8-11].
Reward-associated/Risky decision-making skills FRN, P300 Balloon Analogue Risk Task (BART; [11,12]) Personality
measures by means of BIS/BAS scales [13], BSSS [14],
and I7 [15,16].
Stress sensitivity
Endophenotype Abbreviation(s) Assessment
Stress reactivity of the hypothalamic-pituitary-adrenal axis,
indexed by cortisol
HPA Cortisol responses to laboratory stressors, including
public speaking, high speed mathematics, mental
arithmetic tasks [17,18].
Stress reactivity of the autonomic nervous system, including
blood pressure, heart rate, heart rate variability responses
ANS, BP, ECG, HR, HRV ANS responses to laboratory stressors, including
public speaking, high speed mathematics, mental
arithmetic tasks [17,18].
Huizink et al. BMC Public Health 2012, 12:350 Page 2 of 8
http://www.biomedcentral.com/1471-2458/12/350
were eligible to be part of this NR population, the other
n = 549 were not selected based on their age (< 11 years
old) or lack of permission to be contacted for follow-up
research. Of these 1161 eligible individuals, N= 990
(85.3%) participated in T1, of which N= 711 in the stress
procedure, and N= 110 in the EEG procedure. For more
details on the NR population, please see the section ‘Re-
sponse’ further down below and Figure 1.
We further enriched this NR sample with a high risk
(HR) population of adolescents. The HR population of
adolescents included participants with a familial risk for
substance use disorders. These HR adolescents presum-
ably have an increased risk to show altered endopheno-
typic characteristics due to their genetic vulnerability for
substance use disorders. They all had at least one parent
with a substance use disorder (alcohol or illicit drugs),
Table 2 Main outcomes of the JOiN study assessed at T1 and/or T2
Behaviour Data-wave Instrument
Alcohol use disorder: symptoms of abuse and dependence T1 Adolescent: DISC [19], Parent: CIDI [20].
Cannabis use disorder: symptoms of abuse and dependence T1 Adolescent: DISC [8,19], Parent: CIDI [20].
Other substance use disorder: symptoms of abuse and dependence T1 Adolescent: DISC [8,19], Parent: CIDI [20].
Ever use of nicotine, alcohol, cannabis or other drugs T1, T2 Self-reported Substance Use Questionnaire
Age of onset of nicotine, alcohol, cannabis or other drugs T1, T2 Self-reported Substance Use Questionnaire
Frequency and quantity of use of nicotine, alcohol, cannabis or other drug use T1, T2 Self-reported Substance Use Questionnaire
Level of drunkenness or being stoned last time alcohol or cannabis were used T1, T2 Self-reported Substance Use Questionnaire
Figure 1 Flow chart of participation of the normal risk (NR) population.
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for whom treatment was necessary and provided by
Bouman GGZ, the primary addiction care provider in
the city of Rotterdam and the surrounding area (Zuid-
Holland), and were considered as HR for our study pur-
pose. The parent(s) of these adolescents were recruited
from a consecutive series of patients referred to Bouman
GGZ in the period of May 2009 – November 2011. For
a small number of HR participants (n = 6) of whom the
parent had a substance use disorder, the parent was not
in treatment, but parent and adolescent were recruited
by word of mouth. For these parents, substance use dis-
order was ascertained with a standardized diagnostic
interview (CIDI; [20]) prior to participation of the ado-
lescent in the study. In total, N = 83 HR adolescents
were included in the JOiN study. Other inclusion criteria
for this HR group of adolescents were similar to those of
the NR population. We specifically checked for (severe)
mental retardation and epilepsy, which were considered
exclusion criteria for EEG measures.
Power of the study
Our sample size was calculated to be at least N= 600 in
order to have enough power to run our analyses. For
continuously distributed variables (such as number of
cigarettes smoked, number of alcoholic beverages con-
sumed), such a sample size yields a power of 0.99 to
show a contribution to the explained variance of 5% in a
linear regression model with 10 predictors, for main
effects and/or interactions (alpha set on 0.05). For cat-
egorical outcome variables with a rate of 12%, a sample
size of N= 600 yields a power of> 90% to demonstrate a
Relative Risk (RR) of 2 (alpha set on 0.05). Because the
study has several measurements on behavior and sub-
stance use repeated over time, the accuracy of measuring
the true underlying value will be increased, which will
add to the statistical power for these measurements.
Also, the addition of a high risk sample of adolescents
will increase the frequency of risk alleles in our total
study sample. The program Quanto V was used for gen-
etic power analyses for continuous outcomes (e.g. num-
ber of cigarettes smoked). For the estimate of power to
detect main effects of genes, we assumed a ‘disorder’ al-
lele frequency of 0.35, which is based on actual allele fre-
quencies of DRD2 and DRD4 SNPs that were genotyped
in a Finnish Twin study, very recently (Kaprio, personal
communication). For continuous outcomes, the study
was estimated to have over 80% power to detect a gen-
etic main effect and a G*E interaction effect that
accounts for 10% or more of the total variance.
Study procedure and data collection
The study was approved by the Medical Ethics Commit-
tee of the Erasmus Medical Center, the Netherlands, and
was conducted in accordance with the declaration of
Helsinki. Written informed consent was obtained from
all participating adolescents and their parents.
Participants for the NR population were informed
about the study through mail sent to their home address,
and a subsequent telephone call to invite them to par-
ticipate in the baseline assessment (T0, [21]). Data for
T0 were collected via mailed packages containing ques-
tionnaires sent to the participants and their parents. If
the participants agreed to participate, but did not return
their questionnaires in time, they were reminded
through a telephone call from the researchers for several
times (maximally 3) if needed. Data from T0 were
scanned using Teleform into data-files and were visually
checked for missing data or errors by the researchers.
NR adolescent participants at T0 were approached by
telephone by our researchers for the T1 assessment and
the general goals of the JOiN study were explained.
Appointments were made for a visit to (a) the Erasmus
Medical Center or a testing facility near to the partici-
pants’ home address and (b) the Erasmus Behavioral Lab
(Erasmus University Rotterdam) to measure the endo-
phenotypes under study in two experimental sessions.
The NR adolescents first participated in a stress proced-
ure, conducted at a laboratory of the Erasmus Medical
Center, Department of Child and Adolescent Psychiatry.
One hundred and ten of these NR adolescents (native
Dutch adolescents, 59 males, ranging from 12 to 20 years
old, mean age = 15.26, SD= 2.17) subsequently partici-
pated in an EEG procedure at the Erasmus Behavioral
Lab (Erasmus University Rotterdam). More details about
these EEG procedures are provided below.
The parents of the HR population were informed
about the study by the treatment staff of Bouman GGZ.
All patients who had a child in the age range of 12–
20 years received an information package on the study,
and were asked if they approved of their child to partici-
pate. If they agreed, the patients and their child were
screened by telephone on inclusion and exclusion cri-
teria. If they were found to be eligible, an appoint-
ment was made for T1 assessments. 107 families were
approached which included at least 131 eligible adoles-
cents. Of these, 83 adolescents from 64 families partici-
pated in the study.
Prior to the experimental sessions (see below), ques-
tionnaires and four tubes for assessment of salivary cor-
tisol levels on a normal day were sent to the participants
by mail. Detailed written instructions were given on the
time and manner of sample collections, and to preserve
the tubes in the freezer until the testing day. Participants
were instructed to provide the first sample directly upon
awakening (Cort1), the second 30 minutes afterwards
(Cort2), the third at 12 p.m. (Cort3) and the fourth at
8 p.m. (Cort4). Participants then brought the frozen
tubes to the session that collected their endophenotypic
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characteristics, along with questionnaire data on the
main outcomes and covariates. The experimental ses-
sions included a stress procedure and an EEG procedure,
which together lasted approximately three to four hours.
The stress procedure took place during the afternoon
in order to minimize differences in cortisol levels due
to normal diurnal variations. The experiment leader
explained the procedure before the session started. The
electrodes of the electrocardiogram were attached and
participants were told to breathe normally and to relax.
For the NR population, this procedure started with fill-
ing out a questionnaire set, followed by a ten minute
pre-task resting period, after which the social stress tasks
began. For the HR sample, the questionnaire set was
filled out shortly before the EEG procedure, but the
stress procedure similarly started with a ten minute pre-
task resting period. The stress session ended with a five
minute recovery period and a subsequent calm nature
documentary that was shown for 25 minutes for further
relaxation. After each period/task, during the middle of
the movie and at the end of it, the participant was asked
to passively drool into a test tube in order to collect
salivary cortisol. In total, six test tubes were filled with
saliva on the day of the testing session, and heart rate
was monitored continuously using a three-lead electro-
cardiogram throughout the entire stress procedure,
which lasted for approximately 90 minutes. Also, blood
pressure was monitored continuously, using a Portapress
device. All saliva samples were kept in a freezer at
−20 degrees Celsius until data collection was complete.
All samples were sent to the laboratory (Kirschbaum
Laboratory in Dresden, Germany) for analysis. A time-
resolved fluorescence immunoassay was used in order
to determine the cortisol concentration in the saliva
samples. Heart rate data were stored offline to be ana-
lyzed at a subsequent moment and were visually checked
for artefacts.
The EEG session lasted approximately 75 minutes in
total. Participants were seated on a comfortable chair in
a light and sound-attenuated room. While filling in a
questionnaire set, the EEG electrodes were attached.
Hereafter, participants conducted a visual novelty odd-
ball task and a gambling/decision-making paradigm (i.e.,
the Balloon Analogue Risk Task; BART).
The EEG was recorded with BioSemi Active-Two
using 34 scalp sites (10–10 system, and two additional
electrodes at FCz and CPz) with Ag/AgCl active electro-
des mounted in an elastic cap. Two electrodes were
attached to the left and right mastoids as reference elec-
trodes. To be able to correct for ocular artifacts, two
electrodes were placed next to each eye for horizontal
electrooculogram (HEOG) and two electrodes were
placed above and below the left eye for vertical electroo-
culogram (VEOG). Online signals were recorded with a
low-pass filter of 134 Hz. All signals were digitized with
a sampling rate of 512 Hz and 24 bit A/D conversion.
EEG data were stored offline to be analyzed (using Brain
Vision Analyzer 2) at a subsequent moment and then
off-line referenced to mathematically linked mastoids,
filtered, ocular corrected, baseline corrected, visually
checked for artefacts and finally, relevant epochs were
averaged for relevant artefact free trials at each scalp
site, for each participant. All participants received a gift
certificate worth 50 euro for their participation in the
experimental session.
Besides questionnaire data and endophenotypic data,
DNA was also collected at T1 through saliva or blood
samples from the adolescents. Blood and buccal swab
samples were stored at −20 degrees Celsius. Saliva sam-
ples contained in Oragene containers were stored at
room temperature. Genotyping will be conducted by
PCR (polymerase chain reaction) in a genetic laboratory.
Furthermore, diagnostic interview data were collected
at T1. Parents of the participants who had completed
the experimental sessions were contacted by telephone
by a research assistant to make an appointment for inter-
views with the parents as well as the adolescents. The
Composite International Diagnostic Interview (CIDI;
[20]) pertains to symptoms of psychopathology and was
completed by either one or both parents 73.4% (727/990)
participated in the interviews, of which 35.2% mother,
5.0% father, 59.8% both). The Diagnostic Interview
Schedule for Children (DISC; [19,22]) pertains to symp-
toms of psychopathology in youth and was completed
by one of the parents about their child (parent-report
version) and by the participants about themselves (self-
report version).
Finally, T2 assessment for the NR and HR adolescents
was conducted approximately one year after T1 through
mailed packages of questionnaires (see procedure for T0).
Data collection normal risk population only
At baseline (T0, 2003–2004) general demographic infor-
mation (i.e. gender, age, social-economic status, and
ethnicity) was collected from the sample of NR partici-
pants of the general population as well as information
on behavioural and emotional problems. To obtain a
complete view on adolescent’s problem behaviours, infor-
mation from multiple informants and differences among
them is needed [23]. Adolescents’ behavioural and emo-
tional problems were assessed with: Child Behaviour
Checklist (CBCL/6-18; parent report); Youth Self-Report
(YSR); Teachers’ Report Form (TRF). The content of
the above mentioned scale is the same for all three
informants, although the scales vary in some items across
informants. All items, which are scored 0 (not true),
1 (somewhat or sometimes true) or 2 (very true or often
true), are based on the preceding 6 months. Eight
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syndrome scores are derived: Withdrawn/Depressed,
Somatic Complaints, Anxious/Depressed, Social Problems,
Thought Problems, Attention Problems, Rule-Breaking
Behavior, and Aggressive Behaviour. Good reliability and
validity of the instruments have been replicated for the
Dutch translation [24-26].
Data collection at T1: normal risk and high risk population
Predictor variables
Genotype Polymorphisms in several genes related to
our endophenotypes and/or our outcome of interest will be
determined, including (but not restricted to) the D2/4 (DRD2/
DRD4) dopamine receptor gene, the mu-opioid receptor
gene (OPRM1), the GABA-a receptor gene (GABRA2),
the muscarinic acetylcholine receptor gene (CHRM2),
and the Catechol-O-Methyltransferase (COMT) gene.
Endophenotypes An overview of endophenotypes cov-
ered in the JOiN study is provided in Table 1. For the
first neurobiological pathway, behavioural disinhibition,
several cognitive indices and personality measures were
included in our study design. We used a visual novelty
oddball paradigm to elicit a P300 ERP response. The
amplitude of the P300 has been proposed to reflect
attentional allocation, with reduced P300 amplitudes re-
ferring to inefficient allocation of attentional resources
in processing task-relevant cognitive information (e.g.
[8,9]). Furthermore, the automatic response mode version
of the Balloon Analogue Risk Task (BART; see [12,27]
for further details) was used as an index of reward-
associated/risky decision-making skills. In addition, by
pairing this measure with EEG recordings, we were
also able to investigate the brain’s feedback processing
mechanisms during risky decision-making (i.e., the feed-
back-related negativity (FRN) and the feedback-related
P300 amplitude). Moreover, personality traits encompass-
ing three related personality traits of impulsivity, sensa-
tion seeking tendencies and sensitivity for reward were
assessed, using the I7 questionnaire [15,16], the Brief Sen-
sation Seeking Scale (BSSS; [14]) and BIS/BAS scales
[13,28], respectively. The second neurobiological pathway,
individual sensitivity to stress, is measured in a standard
laboratory setting. Three tasks are used to elicit a physio-
logical stress response of the participants, after baseline
measures are collected. Physiological stress responses
include cardiovascular reactivity measures (blood pres-
sure, electrocardiogram), and hypothalamic-pituitary-adrenal
(HPA) axis response (cortisol). Tasks include (1) a public
speaking task, (2) a high speed mathematics task on the
computer, and (3) a mental arithmetic task. These tasks
have repeatedly been shown to elicit stress responses
(e.g. [17,18,29]).
Covariates General background characteristics were
collected on gender, SES, age, weight and height (to
determine Body Mass Index), pubertal stage by Tanner
[30,31], oral contraceptive use (females only), medication
use, birth outcome information reported by the parent(s).
Extensive measures of symptoms of psychopathology
were collected in both NR and HR adolescents, including:
CBCL, YSR, TRF (see T0), Antisocial Process Screening
Device (APSD; [32]); Multidimensional Anxiety Scale for
Children (MASC; [33]). In addition, information on tem-
perament was collected with the Emotionality Activity
Sociability scale (EAS; [34]). Occurrence of life events
were also assessed using a self-report questionnaire devel-
oped by the TRAILS consortium [35,36].
Information on family and parental factors included
parental substance use (reported by the parent(s)), includ-
ing information on parental substance use during preg-
nancy, parenting style as reported by the adolescent and
parent (‘My memories of upbringing-Child; EMBU’ [37])
and the ‘Alabama Parenting Questionnaire’; [38]).
Outcome variables An overview of the most important
outcomes for the study aims of the JOiN study is listed
in Table 2. To determine symptoms of alcohol, cannabis
and other drug abuse and dependence, based on DSM-
IV criteria, a highly structured respondent-based inter-
view, the NIMH Diagnostic Interview Schedule for
Children (DISC) was applied. Unless otherwise specified,
the timeframe of the DISC is the past 12 months. The
DISC has two parallel forms: DISC-C administered dir-
ectly to the adolescent, and DISC-P administered to the
parent or parent substitute. Both are used in the present
study. The reliability and validity of the DISC have been
supported by previous studies [19,22]. Trained and certi-
fied students administered the DISC.
To assess age of onset of substance use of adolescents,
frequency of substance use, quantity of use, and level of
drunkenness or being stoned, a self-reported Substance
Use Questionnaire was used, including items on (1) age
at first use, (2) (a) monthly, yearly and lifetime preva-
lence of use, and (b) monthly, yearly, and lifetime pre-
valence of intensive use (i.e. drunkenness for alcohol
users); (3) (a) quantity of alcohol use during the week,
and (b) during weekends; (4) (a) number of weekdays and
(b) number of weekend days in which alcohol was con-
sumed; (5) the level of drunkenness, and being stoned the
last time alcohol or cannabis was consumed, respectively.
Response
Normal risk population
The response rates for the NR sample are illustrated in
Figure 1 (flowchart). The 990 individuals that took part
in T1 did not differ from those who did not (n = 171)
with regard to gender or psychopathology, although
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they did have a slightly higher social economic status
(p< .001). The 711 individuals that participated in the
stress procedure did not differ from those who did not
(n = 990 – 711= 279) regarding T0 psychopathology, but
they did show somewhat more internalizing problems
during T1 (p< .05) and more girls participated than
boys (p< .01). No differences were found between the
110 individuals that participated in the EEG experiment
and those who did not.
High risk population
Estimation of the precise number of eligible adolescents
for the HR population, of whom at least one parent
was a patient at Bouman GGZ from May 2009 until
November 2011 is difficult, because there was no satis-
factory registry of the number or age of children of this
patient group of Bouman GGZ at the start of our study.
Therefore, we did not attempt to identify the overall
response rate of this population. However, several remarks
regarding the response of this particular subsample can
be made. First, when patients at Bouman GGZ were
approached by our researchers or by their counsellors to
ask for their approval to have their adolescent child con-
tacted by our researchers, we noticed that a large number
of patients had limited contact or disturbed relations with
their child. This first hurdle reduced the number of avail-
able adolescents for our study. Second, if the parent
agreed to have their child contacted by our researchers,
some of the adolescents themselves did not want to
be confronted with the addiction problem of one of their
parents, and refused to participate for that reason, or did
not have time or motivation to take part in the extensive
measures. Third, perhaps because of the adolescent age of
our population, if arrangements were made to participate
in our study, about half of the adolescents were no-shows
at the set time and date for their assessment. Nonetheless,
of the 107 approached families, we were able to include
n=83 participants in the HR population.
Discussion
Limitations
As described in the response section, there was a slight
response bias in the NR population with more female,
higher socioeconomic status individuals participating.
Since children whose parents did not speak Dutch were
excluded, the group of ethnic minorities is underrepre-
sented. Moreover, to limit the amount of time spent
by the adolescents and their parent(s) in order to main-
tain feasibility and keep the burden for participants
acceptable, we did not include all measures that might,
in retrospect, be useful for examining additional hypo-
theses in our study. For instance, although we included
information on several personality characteristics, and
on various symptoms of psychopathology, we did not
include the whole spectrum of personality that might
underlie the occurrence of risk taking behaviour such as
substance use. Thus, the breadth of focus may be limited,
but the counterbalance is offered by detailed information
collected on several occasions on other important fac-
tors. Another weakness of the study is that some possibly
important determinants of psychopathology that operate
earlier in life, such as birth outcomes and prenatal influ-
ences, have been assessed retrospectively or not at all.
Strengths
The longitudinal design of the JOiN study, in which
a normal risk population of adolescents is combined
with a high risk population of adolescents with a familial
vulnerability for substance use disorders, is optimal for
examining the predictive role of endophenotypes of
adolescent substance use.
Furthermore, the combination of different methods,
i.e. stress physiology, electrophysiology, genetics, and
questionnaire data from several informants on a range
of behaviours and environmental factors, in the JOIN
study, enables the investigation of the multifactorial
nature of adolescent substance use. In addition, the
unique element of our study is that various interrelations
among endophenotypic characteristics, and between
genotype and endophenotype can be tested for their
predictive value of substance use. It may therefore con-
tribute to the identification of adolescents at risk for
onset of substance use and those who progress to regu-
lar use and abuse.
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